Kai Yang
Nanjing Tech University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Chengdu Medical College(CN)Wenzhou Medical University(CN)Nanjing University of Science and Technology(CN)Affiliated Eye Hospital of Wenzhou Medical College(CN)First Affiliated Hospital of Guangzhou Medical University(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)Third People's Hospital of Hangzhou(CN)First Affiliated Hospital of Chengdu Medical College(CN)Affiliated Hospital of Shaanxi University of Chinese Medicine(CN)Shanghai Sixth People's Hospital(CN)Guang’anmen Hospital(CN)State Key Laboratory of Respiratory Disease(CN)Southern Medical University(CN)Hainan Medical University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research, Cardiovascular Function and Risk Factors, Nitric Oxide and Endothelin Effects, Ion Channels and Receptors
Most-Cited Works
- → Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts(2022)145 cited
- → Risk factors of perinatal depression in women: a systematic review and meta-analysis(2022)136 cited
- → Exosome-like nanovesicles derived from Phellinus linteus inhibit Mical2 expression through cross-kingdom regulation and inhibit ultraviolet-induced skin aging(2022)101 cited
- → The current status of biodegradable stent to treat benign luminal disease(2017)97 cited
- → Upregulation of Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells From Idiopathic Pulmonary Arterial Hypertension Patients(2021)84 cited
- → Sodium Tanshinone IIA Sulfonate Inhibits Canonical Transient Receptor Potential Expression in Pulmonary Arterial Smooth Muscle from Pulmonary Hypertensive Rats